Clinical White Paper From the “Hadrontherapy for Life” Symposium–Clinical Expansion of Carbon Ion Facilities Worldwide
CIRT is transitioning from pioneering programs to a coordinated global network. Collaborative initiatives and shared data platforms are essential to establish evidence-based indications, optimize biological modeling, and ensure economic sustainability. The "Hadrontherapy-for-Life" initiative calls for a strategic step toward internationally standardized, clinically integrated heavy-ion therapy.
Authors
- Semi Harrabi (ORCID: https://orcid.org/0000-0003-1195-7150)
- V. Letellier
- Siamak Haghdoost (ORCID: https://orcid.org/0000-0002-2867-4774)
- Tatsuya Ohno (ORCID: https://orcid.org/0000-0002-6703-3144)
- Piero Fossati (ORCID: https://orcid.org/0000-0001-9803-242X)
- Juliette Thariat (ORCID: https://orcid.org/0000-0003-4755-496X)
- Ester M. Orlandi (ORCID: https://orcid.org/0000-0001-6495-8574)
- Jacques Balosso (ORCID: https://orcid.org/0000-0003-0714-9003)
- Shigeru Yamada
- Jean Louis Habrand
Institutions
- Centre National de la Recherche Scientifique (FR)
- Gunma University (JP)
- Heidelberg University (DE)
- Centre Hospitalier Universitaire de Grenoble (FR)
- University Hospital Heidelberg (DE)
- National Center for Oncological Hadrontherapy (IT)
- Centre François Baclesse (LU)
- Normandie Université (FR)
- Laboratoire de Physique Corpusculaire de Caen (FR)
- National Institutes for Quantum Science and Technology (JP)
- Centre François Baclesse (FR)
- Délégation Normandie (FR)
- Karl Landsteiner University of Health Sciences (AT)
- Cyceron (FR)
- Université de Rouen Normandie (FR)
- Université de Caen Normandie (FR)
Publication Details
- Journal
- International Journal of Particle Therapy
- Published
- 2025-11-29
- DOI
- https://doi.org/10.1016/j.ijpt.2025.101290
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00